Navigation Links
Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10%
Date:5/1/2008

r M(TM) for use in orthopedics; renewed our tissue recovery agreement with the Euro Atlantic Transplant Alliance; entered into an agreement to distribute the Harvest(TM) Technologies BMAC(TM) System; and engaged BioHorizons to distribute our bone regeneration products in the international dental market. We are very excited about our future."

Mr. Owusu-Akyaw will host a conference call on May 1, 2008 at 9:00 a.m. Eastern Time to discuss first quarter results. You are invited to listen to the conference call by dialing 706-643-1624. The conference will also be simultaneously webcast at http://www.osteotech.com. Automated playback will be available two hours after completion of the live call, through midnight, Thursday, May 15th, by dialing 706-645-9291 and indicating access code 43861543.

Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in providing OsteoBiologic solutions for regenerative medicine to support surgeons and their patients in the repair of the musculoskeletal system through the development of innovative therapy-driven products that alleviate pain, promote biologic healing and restore function. For further information regarding Osteotech, this press release or the conference call, please go to Osteotech's website at http://www.osteotech.com.

Certain statements made throughout this press release that are not historical facts contain forward-looking statements (as such are defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-loo
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
2. Osteotech to Present at Sidoti Conference in San Francisco
3. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
7. Osteotech to Present at the Sidoti Conference in New York
8. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
9. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
10. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
11. Osteotechs Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... device," Nobel laureate Herbert Kroemer famously observed, referring ... the junctures where layers of different materials meet. ... between layers of metal oxides are becoming increasingly ... spintronics, high-temperature superconductors, ferroelectrics and multiferroics. Realizing the ...
(Date:1/15/2014)... 15, 2014 Look inside the new ... for the lab, from fluid handling to instruments to ... ship when you order. , Preferred Solutions features ... from the L/S® model for precise flow control and ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 This webinar ... nonclinical and clinical safety assessment in biosimilars. , Regulatory ... for biosimilar drug development, however the complex nature of ... quality, safety and efficacy extremely challenging. Based on the ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent viruses ... is the Epstein Barr Virus (EBV), and one of these ... chronic inflammatory disease that destroys the body’s joints. As predicted ... high concentrations of EBV DNA in their bodies (1). ...
Breaking Biology Technology:A deeper look at interfaces 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... , , , , , ... for examining , regulatory promoter and enhancer sequences ... cases, the element under investigation (promoter, enhancer) is cloned , ... subsequently , used to transfect cells. Quantification of ...
... , , , , , ... , , , , ... is an essential step in some of the most innovative , ... the cloning of mammals, and vaccination against cancer. Compared to the , ...
... , , , Note: Genomic DNA is fragile. ... Use suitable large-bore pipet tips or equipment when , pipetting genomic ... Place a 1 cm tail sample into a ... be stored at 20C. To minimize possible cross-contamination, , ...
Cached Biology Technology:Genetic Reporter Systems 2Genetic Reporter Systems 3Genetic Reporter Systems 4Principles and applications of electrical cell fusion 2Principles and applications of electrical cell fusion 3Principles and applications of electrical cell fusion 4Principles and applications of electrical cell fusion 5Mouse Tail Genomic DNA Isolation Protocol(1) 2
(Date:7/10/2014)... everyday household items such as washing machines could hold ... new study has claimed., As part of an EPSRC ... including those from the University of Exeter, have shown ... replicated in the natural world to help restock declining ... in essence a built-in feedback control mechanism to maintain ...
(Date:7/10/2014)... Consuming a whole fresh avocado with either an ... A carotenoid (alpha- and beta-carotene) absorption and conversion of ... according to new research (1) published in ... Vitamin A is involved in reproductive health and growth ... and has antioxidant properties. Provitamin A carotenoids, like alpha- ...
(Date:7/10/2014)... 2014Women in the West African nation Burkina Faso ... option. Sayana Press has the potential to increase ... health system and in communities by combining a ... (depot medroxyprogesterone acetate)with the BD Uniject injection system. ... African countries expected to begin introducing Sayana Press ...
Breaking Biology News(10 mins):Feedback control could be key to robust conservation management 2New research: Fresh avocado enhances absorption of essential nutrients for healthy living 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3
... Researchers at the University of Granada (UGR) have studied the ... known population of Polygala balansae in Europe, a ... which was previously thought to be exclusive to Morocco. The ... and included on the list of threatened species. In ...
... taking non-oral and oral hormonal contraceptives were at highest ... study of female German medical students published today in ... women taking non-hormonal contraceptives were at lowest risk for ... "Sexual problems can have a negative impact on both ...
... change is happening today, a Kansas State University professor ... forest and grassland ecosystems. Kendra McLauchlan, assistant professor ... Foundation CAREER Award to examine contrasts in vegetation history ... nitrogen cycling and other ecosystem properties. McLauchlan is the ...
Cached Biology News:Polygala balansae, a new bush to Europe, at risk of extinction in Spain 2Hormonal contraceptives associated with higher risk of female sexual dysfunction 2Hormonal contraceptives associated with higher risk of female sexual dysfunction 3K-State professor using NSF award to study the impact of nitrogen deposition on global change 2